These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23806662)

  • 1. Evaluation of the correlation of caspofungin MICs and treatment outcome in murine infections by wild type strains of Candida parapsilosis.
    Salas V; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Rinaldi MG; Guarro J
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):41-5. PubMed ID: 23806662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.
    Spreghini E; Orlando F; Tavanti A; Senesi S; Giannini D; Manso E; Barchiesi F
    J Antimicrob Chemother; 2012 Sep; 67(9):2195-202. PubMed ID: 22635526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anidulafungin in treatment of experimental invasive infection by Candida parapsilosis: in vitro activity, (1-->3)-beta-D-glucan and mannan serum levels, histopathological findings, and in vivo efficacy.
    Salas V; Pastor FJ; Calvo E; Mayayo E; Quindós G; Carrillo AJ; Guarro J
    Antimicrob Agents Chemother; 2011 Nov; 55(11):4985-9. PubMed ID: 21844324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal therapies in murine infections by Candida kefyr.
    Sanchis M; Martin-Vicente A; Capilla J; Guarro J
    Mycoses; 2016 Apr; 59(4):253-258. PubMed ID: 26857550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro susceptibility of clinical isolates of Candida paparsilosis complex and other Candida species to caspofungin and anidulafungin by Etest.
    Khan Z; Ahmad S; Joseph L; Chandy R; Theyyathel A
    J Chemother; 2011 Apr; 23(2):97-101. PubMed ID: 21571626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killing rates exerted by caspofungin in 50 % serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua.
    Kovács R; Gesztelyi R; Berényi R; Domán M; Kardos G; Juhász B; Majoros L
    J Med Microbiol; 2014 Feb; 63(Pt 2):186-194. PubMed ID: 24184471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
    Brzankalski GE; Najvar LK; Wiederhold NP; Bocanegra R; Fothergill AW; Rinaldi MG; Pattterson TF; Graybill JR
    J Antimicrob Chemother; 2008 Nov; 62(5):1094-100. PubMed ID: 18658194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-susceptible Candida parapsilosis isolates with different degrees of caspofungin susceptibility.
    Dimopoulou D; Hamilos G; Tzardi M; Lewis RE; Samonis G; Kontoyiannis DP
    Antimicrob Agents Chemother; 2014; 58(1):229-36. PubMed ID: 24145540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro and vivo efficacy of caspofungin against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans.
    Földi R; Kovács R; Gesztelyi R; Kardos G; Berényi R; Juhász B; Szilágyi J; Mózes J; Majoros L
    Mycopathologia; 2012 Oct; 174(4):311-8. PubMed ID: 22565489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.
    Barchiesi F; Spreghini E; Tomassetti S; Della Vittoria A; Arzeni D; Manso E; Scalise G
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2719-27. PubMed ID: 16870764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
    Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
    BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
    Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
    Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-kill studies investigating the killing activity of caspofungin against Candida dubliniensis: comparing RPMI-1640 and antibiotic medium 3.
    Varga I; Sóczó G; Kardos G; Majoros L
    J Antimicrob Chemother; 2008 Jul; 62(1):149-52. PubMed ID: 18390882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of an infant infected with refractory C. parapsilosis with caspofungin.
    Ozkaya-Parlakay A; Tezer H; Kazmacan T; Gulhan B; Unal S
    J Trop Pediatr; 2014 Aug; 60(4):329-30. PubMed ID: 24567311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspofungin disk diffusion breakpoints and quality control.
    Brown SD; Traczewski MM
    J Clin Microbiol; 2008 Jun; 46(6):1927-9. PubMed ID: 18400918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.
    Pfaller MA; Diekema DJ; Andes D; Arendrup MC; Brown SD; Lockhart SR; Motyl M; Perlin DS;
    Drug Resist Updat; 2011 Jun; 14(3):164-76. PubMed ID: 21353623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome.
    Kartsonis N; Killar J; Mixson L; Hoe CM; Sable C; Bartizal K; Motyl M
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3616-23. PubMed ID: 16127030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.
    Ghannoum MA; Chen A; Buhari M; Chandra J; Mukherjee PK; Baxa D; Golembieski A; Vazquez JA
    Clin Microbiol Infect; 2009 Mar; 15(3):274-9. PubMed ID: 19210699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.
    Zhang J; Silao FG; Bigol UG; Bungay AA; Nicolas MG; Heitman J; Chen YL
    PLoS One; 2012; 7(8):e44192. PubMed ID: 22952924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.